Invent Medic publishes newsletter on the company’s market launch in Germany and the UK in Q4 2019
Today, Invent Medic publishes a new issue of the company’s newsletter aimed at shareholders, investors and other interested parties.In this issue, CEO Karin Bryder is interviewed on the upcoming launch of Efemia Bladder Support in the major European markets Germany and the UK. Furthermore, the pelvic mesh ban in markets including the US and the UK is highlighted, and how this contributes to a growing interest in Efemia as a surgery-free alternative for women experiencing stress urinary incontinence. Additional topics include the upcoming marketing of Efemia in physical pharmacies in Sweden